Loading...
Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
Therapies that target oncogenes and immune checkpoint molecules constitute a major group of treatments for metastatic melanoma. A mutation in BRAF (BRAF V600E) affects various signaling pathways, including mitogen activated protein kinase (MAPK) and PI3K/AKT/mammalian target of rapamycin (mTOR) in m...
Na minha lista:
| Udgivet i: | Front Cell Dev Biol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7311641/ https://ncbi.nlm.nih.gov/pubmed/32626712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00486 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|